Author | dc.contributor.author | Núñez Vergara, Luis | es_CL |
Author | dc.contributor.author | Squella Serrano, Juan | es_CL |
Author | dc.contributor.author | Bollo Dragnic, Soledad | es_CL |
Author | dc.contributor.author | Marín Catalán, Rigoberto | es_CL |
Author | dc.contributor.author | Pino, L. | es_CL |
Author | dc.contributor.author | Díaz Araya, Guillermo | |
Author | dc.contributor.author | Letelier Muñoz, María Eugenia | es_CL |
Admission date | dc.date.accessioned | 2009-08-26T11:59:05Z | |
Available date | dc.date.available | 2009-08-26T11:59:05Z | |
Publication date | dc.date.issued | 1998-01 | |
Cita de ítem | dc.identifier.citation | GENERAL PHARMACOLOGY 30(1): 85-87 | en |
Identifier | dc.identifier.issn | 0306-3623 | |
Identifier | dc.identifier.uri | https://repositorio.uchile.cl/handle/2250/120785 | |
Abstract | dc.description.abstract | 1. Isradipine and lacidipine, two new drugs that are members of the nitro-aryl-1,4-dihydropyridine family, produced inhibition of both growth cultures and oxygen consumption on epimastigotes of Trypanosoma cruzi Tulahuen strain, at micromolar concentrations.
2. Isradipine was found to be the most potent derivative in both, in growth cultures (I-50=20.8 mu M) and in vivo oxygen uptake (I-50=31.1 mu M).
3. Diltiazem and verapamil, two well-known calcium channel antagonists, lacked inhibitory activity, even at a 100 mu M concentration.
4. The present findings indicate that the trypanocide effects exerted by isradipine and lacidipine are not related with a disruption of the calcium homeostasis of the parasite. | en |
Lenguage | dc.language.iso | en | en |
Publisher | dc.publisher | PERGAMON-ELSEVIER SCIENCE LTD | en |
Keywords | dc.subject | Trypanosoma cruzi | en |
Título | dc.title | Isradipine and lacidipine: Effects in vivo and in vitro on Trypanosoma cruzi epimastigotes | en |
Document type | dc.type | Artículo de revista | |